Literature DB >> 14615730

A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.

Thomas Kühne1, George R Buchanan, Sherri Zimmerman, Lisa A Michaels, Regina Kohan, Willi Berchtold, Paul Imbach.   

Abstract

OBJECTIVE: To analyze prospectively the impact of age at diagnosis in childhood idiopathic thrombocytopenic purpura (ITP). STUDY
DESIGN: International registry from June 1997 to May 2001, with analysis of data from baseline and 6-month-follow-up questionnaires.
RESULTS: Data from 2540 patients were analyzed, including 203 infants (7.6%), 1860 children > or =1 to <10 years of age (69.1%), and 477 children and adolescents between > or =10 and <16 years of age (17.7%). The mean platelet count at diagnosis was similar in all three groups, as was the percentage of patients with initial platelet count <20x10(9)/L. The male/female ratio was highest in infants and decreased with age (P=.009). Immunoglobulin therapy was used more often in infants and corticosteroids in patients > or =10 years of age. Follow-up information at 6 months was available for 1742 children (68.6%). Chronic ITP was seen less frequently in infants (23.1%) than in children >10 years of age (47.3%, P<.0001). Intracranial hemorrhage occurred in 3 of 1742 children during the first 6 months after the diagnosis of ITP.
CONCLUSIONS: Pediatric patients with ITP from infancy to adolescence exhibit heterogeneity in clinical, demographic, and treatment factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615730     DOI: 10.1067/s0022-3476(03)00535-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  46 in total

1.  Chickenpox-associated immune thrombocytopenic purpura.

Authors:  E Mantadakis; S Thomaidis; A Chatzimichael
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

Review 2.  Novel clearance mechanisms of platelets.

Authors:  Renata Grozovsky; Karin M Hoffmeister; Hervé Falet
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

3.  Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report.

Authors:  Tomohide Hayashi; Naoki Akioka; Daina Kashiwazaki; Naoya Kuwayama; Satoshi Kuroda
Journal:  Childs Nerv Syst       Date:  2015-02-08       Impact factor: 1.475

4.  Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?

Authors:  Iris Treutiger; Jukka Rajantie; Bernward Zeller; Jan-Inge Henter; Göran Elinder; Steen Rosthøj
Journal:  Arch Dis Child       Date:  2007-04-25       Impact factor: 3.791

5.  Initial Lymphocyte Count as Prognostic Indicator for Childhood Immune Thrombocytopenia.

Authors:  Sinan Akbayram; Kamuran Karaman; Murat Dogan; Lokman Ustyol; Mesut Garipardic; Ahmet Faik Oner
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-08       Impact factor: 0.900

6.  Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.

Authors:  Rachael F Grace; Jenny M Despotovic; Carolyn M Bennett; James B Bussel; Michelle Neier; Cindy Neunert; Shelley E Crary; Yves D Pastore; Robert J Klaassen; Jennifer A Rothman; Kerry Hege; Vicky R Breakey; Melissa J Rose; Kristin A Shimano; George R Buchanan; Amy Geddis; Kristina M Haley; Adonis Lorenzana; Alexis Thompson; Michael Jeng; Ellis J Neufeld; Travis Brown; Peter W Forbes; Michele P Lambert
Journal:  Am J Hematol       Date:  2018-05-06       Impact factor: 10.047

7.  Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.

Authors:  Thomas Kühne; Willi Berchtold; Lisa A Michaels; Runhui Wu; Hugo Donato; Bibiana Espina; Hannah Tamary; Francesco Rodeghiero; Meera Chitlur; Johannes Rischewski; Paul Imbach
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

8.  Successful management of refractory chronic immune thrombocytopenia with intracranial hemorrhage by emergency splenectomy.

Authors:  Sanjeev Kumar Sharma; Nitin Gupta; Tulika Seth; M Srinivas; Pravas Mishra; Manoranjan Mahapatra
Journal:  Indian J Pediatr       Date:  2011-07-15       Impact factor: 1.967

9.  Newly diagnosed immune thrombocytopenia: update on diagnosis and management.

Authors:  Deepak Bansal; Aruna Rajendran; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2013-10-05       Impact factor: 1.967

10.  Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.

Authors:  Federica Bertuola; Carla Morando; Francesca Menniti-Ippolito; Roberto Da Cas; Annalisa Capuano; Giorgio Perilongo; Liviana Da Dalt
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.